Nuveen
FBIO icon

Nuveen’s Fortress Biotech FBIO Stock Holding History

Nuveen’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,438
Closed -$243K – 3330
2022
Q1 		$243K Buy
11,438
+34
+0.3% +$931 ﹤0.01% 3156
2021
Q4 		$416K Sell
11,404
-1,273
-10% -$56.8K ﹤0.01% 3115
2021
Q3 		$637K Sell
12,677
-3,524
-22% -$172K ﹤0.01% 3119
2021
Q2 		$867K Sell
16,201
-1,366
-8% -$82.4K ﹤0.01% 3054
2021
Q1 		$930K Buy
17,567
+297
+2% +$16.8K ﹤0.01% 2910
2020
Q4 		$821K Sell
17,270
-3,791
-18% -$164K ﹤0.01% 2877
2020
Q3 		$1.28M Buy
21,061
+2,513
+14% +$128K ﹤0.01% 2578
2020
Q2 		$746K Buy
+18,548
New +$689K ﹤0.01% 2747

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Nuveen's FBIO Position: Q2 2022 in Review

Nuveen sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 11,438 shares — an estimated $243K sold.

Nuveen first reported a position in FBIO in Q2 2020 and held it in 8 quarters. The position peaked at $1.28M in Q3 2020. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Nuveen reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 11,438 Fortress Biotech shares in Q2 2022, an estimated $243K.
  • Nuveen first reported a position in Fortress Biotech in Q2 2020 and held it in 8 quarters.
  • Nuveen's Fortress Biotech position peaked at $1.28M in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.